Fungal Infections Are More Common Caused by

You might also like

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 28

Fungal infections are more common caused by

Body chemistry and lifestyle can increase the risk of


fungal infections

Fungi often grow in warm, moist environments. Wearing


sweaty or wet clothes is a risk factor for skin infections
Fungal Infections are Common

Itching

Inflammation
Redness Symptoms &
Swelling

Skin Rash
Causes of Fungal Infections

Unclean & Damp


Unhygienic Environment

Fungi often grow in warm,


moist environments.
Wearing sweaty or wet
clothes is a risk factor for
skin infections Tight Dressing
Fungal Infection

Tinea Corporis- Ringworm of body

Tinea Cruris- groin

Tinea Pedis – foot

Tinea unguium– Nail

T. Capitis – Scalp

T. Versicolor – Small patches of skin


Tinea Corporis

o Tinea Corporis : Ringworm of the Body

o Superficial skin infection

o Itchy ,Ring Shaped Patched

o Well defined edges , Scaling more obvious at edges


Tinea Pedis-Athlete’s Foot

o A common skin infection of the feet caused by fungus

o Causes : swimming pools or in showers, and require a


warm moist environment like the inside of a shoe to
incubate

o Tightfitting shoes
Tinea Cruris

o Tinea Cruris is commonly known as jock itch

o  Infections occur more frequently in the summer or


in warm & wet climates

o Infection can affect the genitals, inner thighs and


buttocks
Tinea Versicolor
o Tinea versicolor is a common fungal infection of the
skin. The fungus interferes with the normal
pigmentation of the skin, resulting in small,
discolored patches.

o The most common areas it affects are the shoulders,


back, and chest

o Patches of skin discoloration, usually on the back,


chest, neck and upper arms, which may appear
lighter or darker than usual

o Mild itching & Scaling


Antifungal Drugs Market Growth in India

 Increase the demand of drugs to combat the related diseases


Antifungal Drugs Market in India

 Increases the awareness toward personal care drives the


antifungal drugs market growth in India.

 Demand for the antifungal drugs market are growing


in prevalence of fungal infection due to patients
awareness
Antifungal Drugs Market in India

Antifungal drugs market is expected to flourish Total Antifungal Market Size = 1100 Crs
in the near future in India.

Demand for the antifungal drugs market are Growing Rate = 16. 71%
growing in prevalence of fungal infection
Antifungal Drugs Market-Key Players

Antifungal Drugs Market, such as Pfizer Inc., Sanofi S.A., Gilead Sciences, Inc., Merck & Co., Inc., Novartis
International AG, Abbott Laboratories, Bayer AG, Enzon Pharmaceuticals, Inc., and GlaxoSmithKline Plc.
Mode of Action-Eberconazole

• Eberconazole is fungicidal or fungistatic depending on the drug concentrations.

• It inhibits the Ergosterol synthesis which is an essential component of the cytoplasmic


membrane. This leads to an alteration in its structure and function, thereby inhibiting the growth
of the fungus.
Mode of Action of Eberconazole

 Also shows anti-inflammatory Properties

 Exhibits Lower MIC Value

 Effective against wide strains of dermatophytes

 Less Relapse Rate

Applied Once or Twice Daily


A comparative study of efficacy and safety of Eberconazole
versus terbinafine in patients of tinea versicolor

Both the treatment groups, i.e., eberconazole and terbinafine were found to be safe and efficacious in
patients suffering from TV (led to improvement in clinical cure and mycological cure).

On comparing both treatment groups, better response was observed with eberconazole as patients
had earlier clinical and mycological cure and no patient relapsed in the follow-up.
Know Your Competitors
SN BRAND NAME MRP COMPANY NAME
1. EBERNET 186 DR. REDDY S LAB

2. EBSPOR 170 INTAS PHARMACEUTICALS


3. EBERWIN SUN PHARMA

4. EBERMAC 150 MACLEODS


5. CRURIX CURATIO

Growing Rate = 49%


Eberconazole Market Size : 17 Crs
Know Your Competitors
Promotional Inputs Plan
New Product Launching Promotion Plan

Month 1st Vist 2nd Visit 3rd Visit


Visual Aid & Ebercos Sample
April-18 Sample Reminder Card
& Gift

May-18 Ebercos Pen Sample LBL

June
SALES PLANNING FOR EBERCOS

Description APRI MAY -18 JUNE-18 July-18 Aug-18 Sept-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 March-
L-18 19

Per MR 100 150 200 200 200 250 250 250 250 300 300 300
In Unit

Sales of 55 550 5500 5500 7150 7150 8250 8250 8250 9900 9900 9900
MRS in Unit 0
Sales Value RS 3.0 6.01 6.01 7.80 7.80 9.01 9.01 9.01 10.82 10.82 10.82
in Lac 1.8
MOTIVATIONAL GIFT FOR STAR BRAND PERFORMERS

Quantity = 500 Units ( In 3 Months April-18 to June-18 )

To Give Brand Performer Certificate

Quantity = 700 Units ( In 3 Months April to June )

3000 Gift Card

ZODIAC SHIRT / ELITE SHIRT

You might also like